CONCLUSION - Aspiration Thrombectomy as the Sole Treatment for Acute and Sub-acute Deep Venous

B. METHODS

Ⅴ. CONCLUSION

Aspiration thrombectomy is a safe and effective treatment for acute proximal DVT.

Clinical mid and long-term results are encouraging. In the background of recent internal bleeding, recent surgery, patients with bleeding disorders, severe hypertension, or recent cardiovascular accident, thrombolysis of suprapopliteal DVT is contraindicated and aspiration thrombectomy could be the alternative treatment choice. The advocacy of aspiration thrombectomy as the sole treatment for acute DVT could also be justified on the basis of cost effectiveness and less potential for vein wall damage.

REFERENCES

1. AbuRahma AF, Samuel EP, John TW, and Hong KN: Iliofemoral Deep Vein Thrombosis: Conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Annals of Surgery 233 ( 6): 752–760, 2001

2. Agarwala S, Bhagwat AS, Modhe J: Deep vein thrombosis in Indian patients undergoing major lower limb surgery: Distribution of the thrombi and its significance.

Indian Journal of Surgery 65 (2): 159-162, 2003

3. Agutter PS, Malone PC: Deep Venous Thrombosis: Hunter, Cruveilhier, Virchow, and Present-Day Understanding and Clinical Practice. Int J Hist Philos Med 1: 7-14, 2011 4. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B,

Forcier A, Dalen JE: A population based perspective of the hospital incidence and case-facility rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 151 (5): 933-938, 1991

5. Anning ST: The historical aspects of venous thrombosis. Med Hist. 1 (1): 28-37, 1957

6. Ashrani AA, Heit JA: Incidence and cost burden of post-thrombotic syndrome.

J Thromb Thrombolysis 28 (4): 465–476, 2009

7. Brotman DJ, Deitcher SR, Lip GYH, Matzdorff AC: Virchow’s triad revisited. Southern Medical Journal 97 (2) : 213-214, 2004

8. Burkitt DP: Varicose Veins, Deep Vein Thrombosis, and Haemorrhoids: Epidemiology and Suggested Aetiology. British Medical Journal 2 : 556-561, 1972

9. Castoldi E, Maurissen LFA, Tormene D, Spiezia L, Gavasso S, Radu C, Hackeng TM, Rosing J, Simioni P: Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency. Haematologica 95 (9): 1563-1571, 2010

10. Comerota AJ: Randomized trial evidence supporting a strategy of thrombus removal for acute DVT. Semin Vasc Surg 23: 192–198, 2010

11. Comerota AJ, Gale SS: Technique of contemporary iliofemoral and infrainguinal venous thrombectomy. J Vasc Surg 43: 185-191, 2006

12. Enden T, Kløw N-E, Sandvik L, Slagsvold C-E, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæ k G, Sandset PM; CaVenT study group:

Catheter-32

directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 7 (8): 1268-1275, 2009

13. Fowkes FJI, Price JF, Fowkes FGR: Incidence of Diagnosed Deep Vein Thrombosis in the General Population: Systematic Review. European Journal of Vascular and Endovascular Surgery 25 (1): 1-5, 2003

14. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG:

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (3 Suppl): 338S–400S, 2004 15. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW;

American College of Chest Physicians. Prevention of venous thromboembolism:

American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (6 Suppl): 381S-453S, 2008

16. Jang MJ, Bang SM, Oh D: Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 9: 85–

91, 2011

17. Jeon YS, Yoon YH, Cho JY, Baek WK, Kim KH, Hong KC, Kim JT: Catheter-directed thrombolysis with conventional aspiration thrombectomy for lower extremity deep vein thrombosis. Yonsei Med J. 1;51 (2): 197-201, 2010

18. Kahn SR, Ginsberg JS: Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 164: 17–26, 2004

19. Kahn SR, Lamping DL, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Shrier I: VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. Journal of Clinical Epidemiology 59: 1049–1056, 2006

20. Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM, Thompson MM, Holt PJE: A Systematic Review of Percutaneous Mechanical Thrombectomy in the Treatment of Deep Venous Thrombosis. Eur J Vasc Endovasc Surg 41, 554-565, 2011

21. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ:

Antithrombotic therapy for venous thromboembolic disease: American college of chest

physicians evidence based clinical practice guidelines (8th ed.). Chest 133(6 Suppl.):

454S-545S, 2008

22. Kuipers S, Schreijer AJ, Cannegieter SC, Buller HR, Rosendaal FR, Middeldorp S:

Travel and venous thrombosis: a systematic review. J Intern Med. 262 (6): 615-634, 2007

23. Kwon SH, Oha JH, Seob TS, Ahn HJ, Park HC: Percutaneous aspiration thrombectomy for the treatment of acute lower extremity deep vein thrombosis: is thrombolysis needed? Clinical Radiology 64: 484-490, 2009

24. Kyrle PA, Eichinger S: Is Virchow’s triad complete? Blood 114: 1138-1139, 2009 25. Laiho MK, Oinonen A, Sugano N, Harjola VP, Lehtola AL, Roth WD, Keto PE, Lepäntalo

M: Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. European Journal of Vascular and Endovascular Surgery 28 (4): 391–396, 2004

26. Lee AD, Stephen E, Agarwal S, Premkumar P: Venous Thrombo-embolism in India European Journal of Vascular and Endovascular Surgery 37 (4): 482-485, 2009 27. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG,

Demers C, Kovacs M: A comparison of low molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334 (11): 677–681, 1996

28. Liew NC, Moissinac K, Gul Y: Postoperative venous thromboembolism in Asia: A critical appraisal of its incidence. Asian Journal of Surgery 26 (3): 154-158, 2003 29. Malone PC, Agutter PS: The aetiology of deep venous thrombosis. QJM 99 (9):

581-593, 2006

30. Mewissen MW. Thrombolysis for Lower-Extremity Deep Vein Thrombosis. Semin Vasc Surg 23: 228-234, 2010

31. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH: Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 211 (1): 39–49, 1999

32. Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G: The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 29: 489–496, 2010

33. Nandi PL, Li WS, Leung R, Chan J, Chan H.T: Deep vein thrombosis and pulmonary embolism in the Chinese population. Hong Kong Medical Journal 4 (3): 305-310, 1998 34. Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, Turpie AG, Gallus AS, Planès A,

Passera R, Rouillon A; AIDA investigators: Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 3 (12): 2664- 2670, 2005

35. Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L, Graf A: Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol 36 (4): 1336–1343, 2000

36. Samama MM: An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 160 (22): 3415-3420, 2000 37. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon, Melton LJ: Trends in the

incidence of deep vein thrombosis and pulmonary embolism. A 25- year population-based study. Arch Int Med 158: 585-593, 1998

38. van Hylckama VA, van der Linden IK, Bertina RM, Rosendaal FR: High levels of factor IX increase the risk of venous thrombosis. Blood 95 (12): 3678-3682, 2000 39. Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE, Antonacci VP, D’Othée BM,

Hofmann LV, Cardella JF, Kundu S, Lewis CA, Schwartzberg MS, Min RJ, Sacks D:

Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 17: 417–434, 2006

40. Vidaud D, Emmerich J, Sirieix ME, Sie P, Alhenc-Gelas M, Aiach M: Molecular basis for antithrombin III type I deficiency: three novel mutations located in exon IV. Blood 78: 2305-2309, 1991

41. Virchow RLK. Thrombosis and Embolie, 1846–1856. In: Barth JA, ed. Klassiker der Medizin herausgegeben von Karl Sudhoff, Leipzig, 1910; translated by Matzdorff AC, Bell WR. Canton, Science History Publications, 1998.

42. Weill-Engerer S, Meaume, S, LahlouA. et al: Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study. J Am Geriatr Soc 52 (8):

1299–1304, 2004

43. White RH: The epidemiology of venous thromboembolism. Circulation 107: I-4-I-8, 2003

심부 정맥 혈전증과 관련된 증상을 보였다. 장기 추적 관찰 기간 동안 남아있던 52 명의 환자들에서 78.8% (41/52 명)의 환자들은 재발 소견 없었고 21.1% (11/52 명)은 재발 소견을 보였다. 71.1% (37/52 명)의 환자들은 장기추적관찰에서 무증상이었으며 28.8% (15/52 명)의 환자들은 심부 정맥 혈전증과 관련된 증상을 보였다.

결론: 흡인 혈전 제거술은 급성 근위부 심부 정맥 혈전증의 치료에 있어서 주요합병증 없이 안전하고 경제적이며 효과적인 치료 방법이다. 중 장기 추적 결과에서도 다른 치료방법과 유사한 임상결과를 보였다.

핵심어: 심부정맥혈전증, 혈전용해술, 혈전제거술, 카테터, 메이-써널 증후군.

문서에서 Aspiration Thrombectomy as the Sole Treatment for Acute and Sub-acute Deep Venous Thrombosis (DVT) of the Lower Extremity: mid and long-term clinical results (페이지 42-49)